DEA Approves Syndros, a Pharma Cannabis Solution, for Schedule II Status
The Drug Enforcement Administration has awarded a Schedule II classification for a cannabis solution, Syndros. It’s approved to treat nausea and vomiting, which many cancer patients suffer during chemotherapy. But many patients are already using medical marijuana to handle those same problems.